Seeing Is Believing
Currently out of the existing stock ratings of Sean Lavin, 93 are a BUY (78.15%), 26 are a HOLD (21.85%).
Analyst Sean Lavin, currently employed at BTIG, carries an average stock price target met ratio of 83.31% that have a potential upside of 25.99% achieved within 266 days.
Sean Lavin’s has documented 209 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TCMD, Tactile Systems Technology at 05-Nov-2024.
Analyst best performing recommendations are on TRXC (ASENSUS SURGICAL).
The best stock recommendation documented was for TRXC (ASENSUS SURGICAL) at 5/9/2018. The price target of $52 was fulfilled within 40 days with a profit of $24.96 (92.31%) receiving and performance score of 23.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$388
$6.98 (1.83%)
$355
2 years 22 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$235
2 years 22 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$380
$-1.02 (-0.27%)
$350
2 years 23 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
2 years 1 months 12 days ago
(12-Oct-2022)
1/2 (50%)
$57.23 (23.57%)
20
Sell
$235
$-146.02 (-38.32%)
$275
2 years 4 months 9 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
142
Which stock is Sean Lavin is most bullish on?
What Year was the first public recommendation made by Sean Lavin?